Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Kennedy Krieger Institute to study Viking Therapeutics' thyroid beta agonists for X-ALD

Nov. 26, 2015

University of Ulster describes apelin receptor agonists

Nov. 25, 2015

Bristol-Myers Squibb reports GPR40 modulators

Nov. 25, 2015

ObsEva and Kissei sign development and commercialization agreement for KLH-2109

Nov. 25, 2015

Pharmacological chaperone shows promise for GM1 and Morquio B lysosomal diseases

Nov. 24, 2015

U.S. Department of Health & Human Services introduces CB1 receptor ligands

Nov. 24, 2015

Bristol-Myers Squibb reports GPR40 modulators

Nov. 24, 2015

Vitamin D analogue DP-001 may be superior for treating secondary hyperparathyroidism

Nov. 24, 2015

MediciNova to begin phase IIa study of MN-001 for hypertriglyceridemia in patients with NASH

Nov. 24, 2015

Janssen submits NDA for Invokamet XR for type 2 diabetes

Nov. 23, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...